MacroGenics
MGNX
#8480
Rank
A$0.26 B
Marketcap
A$4.24
Share price
-3.25%
Change (1 day)
31.44%
Change (1 year)

Market capitalization of MacroGenics (MGNX)

Market cap: A$0.26 Billion

As of March 2026 MacroGenics has a market cap of A$0.26 Billion. This makes MacroGenics the world's 8480th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of MacroGenics from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026A$0.26 B77.06%
2025A$0.15 B-53.35%
2024A$0.32 B-62.79%
2023A$0.87 B44.49%
2022A$0.60 B-55.34%
2021A$1.35 B-18.83%
2020A$1.67 B

End of Day market cap according to different sources

On Mar 18th, 2026 the market cap of MacroGenics was reported to be:

A$0.27 Billion
by Nasdaq info icon info icon
A$0.26 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
A$220.82 B 81,923.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$1.167 T 433,737.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$269.32 B 99,939.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$249.32 B 92,510.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$402.40 B 149,368.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$171.86 B 63,737.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
A$1.20 B 348.79%๐Ÿ‡บ๐Ÿ‡ธ USA